- Year Founded
- Latest Deal Type
- Financing Rounds
Want detailed data on 3M+ companies?
What you see here scratches the surfaceRequest a free trial
Want to dig into this profile?
We’ll help you find what you needLearn more
Manufacturer of peptides and polyclonal antibodies intended for drug, vaccine and diagnostic development organizations.
72 As of 2022
|Company Name||Financing Status||Location||Employees||Total Raised||Last Financing Date/Type||Last Financing Amount|
|000 0000000000||Formerly VC-backed||San Jose, CA||000||000000&0|
7Total Documents Applications and Grants
000Total Patents Families
000Expiring in next 12 mo
|Publication ID||Patent Title||Status||First Filing Date||Technology (CPC)||Citations|
|EP-2688904-B1||Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy||Active||21-Mar-2011||0000000000|
|CA-2830772-A1||Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy||Active||21-Mar-2011||0000000000|
|CA-2830772-C||Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy||Active||21-Mar-2011||0000000000|
|Investor Name||Investor Type||Holding||Investor Since||Participating Rounds||Contact Info|
Vivitide Investments (2)
|Company Name||Deal Date||Deal Type||Deal Size||Industry||Lead Partner|
|00000000 0000||12-Dec-2019||0000000000||Biotechnology||000000 00|